17. 多系統萎縮症 Multiple system atrophy Clinical trials / Disease details
臨床試験数 : 119 / 薬物数 : 138 - (DrugBank : 44) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 111
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05104476 (ClinicalTrials.gov) | November 16, 2021 | 15/10/2021 | A Study of Lu AF82422 in Participants With Multiple System Atrophy | Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multi-centre Study to Assess the Efficacy, Safety and Tolerability of Lu AF82422 in Patients With Multiple System Atrophy | Multiple System Atrophy | Drug: Lu AF82422;Drug: Placebo | H. Lundbeck A/S | NULL | Active, not recruiting | 40 Years | 75 Years | All | 64 | Phase 2 | United States;Japan |